FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR+13.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+13.0%/yr
Quarterly compound
Percentile
P80
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 20.49% |
| Q3 2025 | 5.22% |
| Q2 2025 | 21.08% |
| Q1 2025 | -67.65% |
| Q4 2024 | -21.21% |
| Q3 2024 | -30.00% |
| Q2 2024 | 53.00% |
| Q1 2024 | -167.19% |
| Q4 2023 | -3.29% |
| Q3 2023 | 5.88% |
| Q2 2023 | 21.18% |
| Q1 2023 | -78.35% |
| Q4 2022 | 14.19% |
| Q3 2022 | -179061.21% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |